TOCQUEVILLE ASSET MANAGEMENT L.P. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$620,000
-48.4%
4,571
+4.4%
0.01%
-40.0%
Q3 2018$1,202,000
-15.5%
4,378
-36.3%
0.02%
-16.7%
Q2 2018$1,423,000
+29.7%
6,871
+3.5%
0.02%
+28.6%
Q1 2018$1,097,000
-2.5%
6,640
-19.2%
0.01%
+7.7%
Q4 2017$1,125,000
-70.2%
8,216
-70.4%
0.01%
-69.8%
Q3 2017$3,780,000
+14.8%
27,766
+2.4%
0.04%
+10.3%
Q2 2017$3,292,000
+14.7%
27,1160.0%0.04%
+11.4%
Q1 2017$2,870,000
+39.7%
27,116
+34.1%
0.04%
+34.6%
Q4 2016$2,054,000
+39.4%
20,216
+40.1%
0.03%
+44.4%
Q3 2016$1,473,000
-54.7%
14,430
-47.0%
0.02%
-10.0%
Q2 2016$3,250,000
+101.9%
27,250
+81.2%
0.02%
-4.8%
Q1 2016$1,610,000
+13.4%
15,035
+14.8%
0.02%
+10.5%
Q4 2015$1,420,000
+107.3%
13,100
+63.8%
0.02%
+111.1%
Q3 2015$685,000
-15.1%
8,0000.0%0.01%
-10.0%
Q2 2015$807,000
-47.7%
8,000
-60.0%
0.01%
-44.4%
Q1 2015$1,542,000
+93.2%
20,000
+33.3%
0.02%
+100.0%
Q4 2014$798,000
+69.8%
15,000
+50.0%
0.01%
+80.0%
Q3 2014$470,000
-24.6%
10,0000.0%0.01%
-16.7%
Q2 2014$623,000
-2.5%
10,000
+5.3%
0.01%
-25.0%
Q1 2014$639,000
+21.5%
9,500
-5.0%
0.01%
+14.3%
Q4 2013$526,000
+34.9%
10,000
+11.1%
0.01%
+40.0%
Q3 2013$390,000
-30.5%
9,000
-40.0%
0.01%
-37.5%
Q2 2013$561,00015,0000.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders